Menarini Asia-Pacific, Astellas partner to commercialise Smyraf in Taiwan

By NS Healthcare Staff Writer

13 Sep 23

The exclusive licensing partnership agreement provides Astellas with a total of up to €5.5m, in upfront and milestone…

PharmaceuticalsPartnerships and Licensing Agreements

Broad Institute enters into new research collaboration with Novo Nordisk

By NS Healthcare Staff Writer

07 Sep 23

The new research alliance will help advance three programmes over the next three years, of which two programmes…

PharmaceuticalsPartnerships and Licensing Agreements

US government announces $1.4bn funding for new Covid-19 vaccines, therapeutics

By NS Healthcare Staff Writer

23 Aug 23

The funding under Project NextGen includes $1bn to BARDA partners for vaccine clinical trials, $326m to Regeneron for…

PharmaceuticalsManufacturing

Evotec wins $74m contract from US DOD for monoclonal antibody development

By NS Healthcare Staff Writer

06 Jul 23

Under the contract, Evotec Biologics will develop drug product prototype(s) from discovery through the execution of Phase 1…

PharmaceuticalsDrug discovery

Bayer to license Cedilla’s selective inhibitors in precision oncology

By NS Healthcare Staff Writer

02 Jun 23

The license agreement provides Bayer with exclusive rights to develop and commercialise Cedilla’s CyclinE1/CDK2 inhibitors that are currently…

PharmaceuticalsPartnerships and Licensing Agreements

InDex Pharmaceuticals, Viatris sign deal to commercialise cobitolimod in Japan

By NS Healthcare Staff Writer

01 Jun 23

Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Astellas, Sony announce research collaboration for ADC platform in oncology

By NS Healthcare Staff Writer

17 May 23

Astellas and Sony will jointly develop and optimise a new ADC platform using KIRAVIA Backbone as a linker,…

PharmaceuticalsPartnerships and Licensing Agreements

Gilead, Arcus expand research partnership to include inflammatory diseases

By NS Healthcare Staff Writer

16 May 23

Arcus will receive an upfront payment of $35m and will commence research programs against up to four targets,…

PharmaceuticalsPartnerships and Licensing Agreements

SERB obtains US rights to SFJ’s ticagrelor reversal agent bentracimab

By NS Healthcare Staff Writer

12 May 23

Bentracimab is a novel, monoclonal antibody fragment that reverses the antiplatelet activity of ticagrelor, an antiplatelet medicine marketed…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Nanobiotix in talks to develop and commercialise cancer drug NBTXR3

By NS Healthcare Staff Writer

08 May 23

The biotechnology company has entered negotiations with a major global pharmaceutical company, for the development and commercialisation of…

PharmaceuticalsPartnerships and Licensing Agreements